Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Medicare Advantage could become the default health-insurance program for all older adults. A recent proposal in Congress would automatically enroll older adults in a Medicare Advantage plan and then ...

A bill introduced by Rep. Buddy Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Humana (NYSE:HUM) plans to cut a third of prior authorizations and refiles a case against the government over its 2025 Medicare Star Ratings cut. Read more here.

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Humana on Monday filed a new lawsuit over the U.S. government's reduction in the health insurer's star ratings for government ...

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

Humana Inc. lost its lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...